Last edition
News about "Anti-Competitive Practices Over Plavix"
French Court Orders Sanofi to Pay Euro 177 Million for Anti-Competitive Practices Over Plavix
A French court has ordered Sanofi to pay 177 million euro after ruling that the company engaged in anti-competitive behaviour to protect sales of its blockbuster blood thinner, Plavix. The decision follows a long-running investigation into allegations that Sanofi misled doctors and pharmacists about the safety of generic versions of the drug.
Anti-Competitive Practices Over Plavix | 25/09/2025 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy